Style | Citing Format |
---|---|
MLA | Safaei M, et al.. "The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study." Immunopathologia Persa, vol. 11, no. 2, 2025, pp. -. |
APA | Safaei M, Mortezaei NT, Azmoudehardalan F, Jafarian A, Niyari EE, Bouzari B (2025). The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study. Immunopathologia Persa, 11(2), -. |
Chicago | Safaei M, Mortezaei NT, Azmoudehardalan F, Jafarian A, Niyari EE, Bouzari B. "The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study." Immunopathologia Persa 11, no. 2 (2025): -. |
Harvard | Safaei M et al. (2025) 'The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study', Immunopathologia Persa, 11(2), pp. -. |
Vancouver | Safaei M, Mortezaei NT, Azmoudehardalan F, Jafarian A, Niyari EE, Bouzari B. The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study. Immunopathologia Persa. 2025;11(2):-. |
BibTex | @article{ author = {Safaei M and Mortezaei NT and Azmoudehardalan F and Jafarian A and Niyari EE and Bouzari B}, title = {The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study}, journal = {Immunopathologia Persa}, volume = {11}, number = {2}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Safaei M AU - Mortezaei NT AU - Azmoudehardalan F AU - Jafarian A AU - Niyari EE AU - Bouzari B TI - The Role of Clinicopathological Features in the Prognosis of Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Study JO - Immunopathologia Persa VL - 11 IS - 2 SP - EP - PY - 2025 ER - |